Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
According to Waldstein, companies should exercise caution to avoid promising drastic weight loss benefits
Market trends affecting future pricing Several trends are worth watching: New GLP-1 receptor agonists entering the market, including orforglipron , survodutide , and retatrutide , will increase competition and could put downward pressure on tirzepatide pricing across both brand-name and compounded channels
Both treatments are administered via a subcutaneous injection, typically once a week
Most capsule products land at 250-500 mcg per capsule, which is within this range, but no human dose-finding trial exists to confirm optimal dosing
US$ 21.48
US$ 22.51
US$ 20.21
US$ 28.12
US$ 21.83
